International

main office:
geneva, switzerland

arrow

general manager:
Meet torsten hoof

oncotypeDX logo

products: oncotype dx Portfolio

globe icon

Our well-established global infrastructure spans more than 90 countries and will help accelerate the launch of our pipeline products. We’re currently focused on expanding Oncotype DX testing in seven key markets: Japan, Germany, United Kingdom, France, Italy, Spain, and Canada.

dna icon

2.1 MILLION WOMEN

are diagnosed with breast cancer each year around the world.

Source: World Health Organization

global icon

The Oncotype DX Breast Recurrence Score continues to gain traction internationally with support from key guideline groups, including the European Society for Medical Oncology (ESMO), St. Gallen, and the National Institute for Health and Care Excellence (NICE). We have approximately 40 oncology sales representatives, as well as talented insurance coverage managers, supporting adoption of Oncotype DX on a global scale.

locations map
legend star

Headquarters

legend circle

Office

patient photo
quotation mark

I will get my life back."

Patient Story

Tanja lives in Germany and describes herself as a very happy person. When she was diagnosed with breast cancer in October of 2015, many thoughts rushed through her head. She was concerned about the danger of the cancer itself, but maybe even more so about the various treatments and operations she was sure to face. Tanja has a fear of needles and was afraid to learn about the path forward. The day she was diagnosed, the then 41-year-old from Rhineland learned about the Oncotype DX test. She was excited to hear that if her Oncotype DX Breast Recurrence Score was within a certain range, she could be safely spared chemotherapy, without reducing her chances of a full recovery. Tanja decided to use Oncotype.

“Based on the results, my doctor advised me against chemotherapy.” This gave Tanja peace of mind and the confidence to “definitely” recommend the test to other eligible patients. “Thanks to the test, I was spared bad side effects, in particular, I was able to keep my hair. That was very important to me.”

Tanja now shares her story wherever she can and met another patient online, who unfortunately wasn’t able to avoid chemotherapy. “I wanted to talk to other patients. Coincidentally, I met a breast cancer patient from my neighborhood. We are now good friends. She is treated with chemotherapy and unfortunately suffers a lot from the side effects.”

Tanja has kept her positive attitude and curiosity throughout this journey, and she is looking forward to traveling once she finishes her rehab. She proudly affirms, “I will get my life back.”

Forward-Looking Statements

This report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be covered by the"safe harbor" created by those sections. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as "believe," "expect,""may," "will," "should," "would," "could," "seek," "intend," "plan," "goal," "project," "estimate," "anticipate" or other comparable terms. All statements other than statements of historical facts included in this report regarding our strategies, prospects, expectations, goals, financial condition, operations, costs, plans and objectives are forward-looking statements. Examples of forward-looking statements include, among others, statements we make regarding expected growth opportunities and market share, future operating results, anticipated results of our sales, marketing and patient adherence efforts, expectations concerning payer reimbursement, and the anticipated results of our product development efforts. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Actual results, conditions and events may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause actual results, conditions and events to differ materially from those indicated in the forward-looking statements include, among others, the risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10-K and our subsequently filed Quarterly Reports on Form 10-Q. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.